{"answers":{"affected":"","exploited":"It is not confirmed as exploited in the wild, but public exploit code for CVE-2023-53734 exists.","fix":"No fix has been published for CVE-2023-53734 yet. Limit exposure of the affected software until one is available.","what":"CVE-2023-53734 is a high-severity SQL injection vulnerability in mayurik dawa-pharma, published on 4 Dec 2025. An attacker can exploit it over the internet without logging in, with no action from the victim."},"fix_prompt":"Check this codebase for CVE-2023-53734 and fix it if it is affected.\n\nWhat it is: CVE-2023-53734 is a high-severity SQL injection vulnerability in mayurik dawa-pharma, published on 4 Dec 2025. An attacker can exploit it over the internet without logging in, with no action from the victim.\nExploitation: It is not confirmed as exploited in the wild, but public exploit code for CVE-2023-53734 exists.\n\nAffected product: mayurik dawa-pharma. No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2023-53734/ (Markdown: https://insights.sbomify.com/CVE-2023-53734/index.md)","id":"CVE-2023-53734","markdown":"https://insights.sbomify.com/CVE-2023-53734/index.md","name":"CVE-2023-53734","record":{"aliases":["GHSA-6q4x-gx2j-mfgh"],"analysis":{"component_type":"web_application","fix_type":"no_fix_stated","impacts":["data_read","privilege_escalation"],"network_reachable":"yes","non_default_config":false,"product_category":"Pharmacy management system","requires_auth":"none","summary":"Unauthenticated attackers can execute SQL queries via the email parameter to access sensitive data and potentially gain administrative access.","user_interaction":"not_required","vuln_class":"sql_injection"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"VulnCheck","cpe":[],"cvss":{"score":8.7,"severity":"high","source":"cna","vector":"CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N","version":"4.0"},"cwes":[{"id":"CWE-89","name":"Improper Neutralization of Special Elements used in an SQL Command"}],"description":"dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"weaponised"},"has_fix":null,"headline":"dawa-pharma-1.0 - SQL Injection via Email Parameter","id":"CVE-2023-53734","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"sql_injection","year":"2023"},"n_packages":0,"n_references":5,"next":{"headline":"WEBIGniter 28.7.23 Cross-Site Scripting (XSS) in User Creation Process","id":"CVE-2023-53735"},"packages":[],"prev":{"headline":"net: sched: cls_u32: Undo tcf_bind_filter if u32_replace_hw_knode","id":"CVE-2023-53733"},"products":["dawa-pharma"],"published":"2025-12-04","related":[],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"CWE Terms of Use","name":"CWE (MITRE)"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":"yes","exploitation":"poc","technical_impact":"partial"},"state":"PUBLISHED","updated":"2026-04-07","vendors":["mayurik"]},"summary":"Unauthenticated attackers can execute SQL queries via the email parameter to access sensitive data and potentially gain administrative access.","url":"https://insights.sbomify.com/CVE-2023-53734/"}